All Title Author
Keywords Abstract

PLOS ONE  2013 

Protection by an Oral Disubstituted Hydroxylamine Derivative against Loss of Retinal Ganglion Cell Differentiation following Optic Nerve Crush

DOI: 10.1371/journal.pone.0065966

Full-Text   Cite this paper   Add to My Lib


Thy-1 is a cell surface protein that is expressed during the differentiation of retinal ganglion cells (RGCs). Optic nerve injury induces progressive loss in the number of RGCs expressing Thy-1. The rate of this loss is fastest during the first week after optic nerve injury and slower in subsequent weeks. This study was undertaken to determine whether oral treatment with a water-soluble N-hydroxy-2,2,6,6-tetramethylpiperidine derivative (OT-440) protects against loss of Thy-1 promoter activation following optic nerve crush and whether this effect targets the earlier quick phase or the later slow phase. The retina of mice expressing cyan fluorescent protein under control of the Thy-1 promoter (Thy1-CFP mice) was imaged using a blue-light confocal scanning laser ophthalmoscope (bCSLO). These mice then received oral OT-440 prepared in cream cheese or dissolved in water, or plain vehicle, for two weeks and were imaged again prior to unilateral optic nerve crush. Treatments and weekly imaging continued for four more weeks. Fluorescent neurons were counted in the same defined retinal areas imaged at each time point in a masked fashion. When the counts at each time point were directly compared, the numbers of fluorescent cells at each time point were greater in the animals that received OT-440 in cream cheese by 8%, 27%, 52% and 60% than in corresponding control animals at 1, 2, 3 and 4 weeks after optic nerve crush. Similar results were obtained when the vehicle was water. Rate analysis indicated the protective effect of OT-440 was greatest during the first two weeks and was maintained in the second two weeks after crush for both the cream cheese vehicle study and water vehicle study. Because most of the fluorescent cells detected by bCSLO are RGCs, these findings suggest that oral OT-440 can either protect against or delay early degenerative responses occurring in RGCs following optic nerve injury.


[1]  Weinreb RN, Khaw PT (2004) Primary open-angle glaucoma. Lancet 363: 1711–1120.
[2]  Bessero AC, Clarke PG (2010) Neuroprotection for optic nerve disorders. Curr Opin Neurol 23: 10–15.
[3]  Calkins DJ (2012) Critical pathogenic events underlying progression of neurodegeneration in glaucoma. Prog Retin Eye Res 31: 702–719.
[4]  Liu CJ, Chaturvedi N, Barnstable CJ, Dreyer EB (1996) Retinal Thy-1 expression during development. Invest Ophthalmol Vis Sci 37: 1469–1473.
[5]  Schlamp CL, Johnson EC, Li Y, Morrison JC, Nickells RW (2001) Changes in Thy1 gene expression associated with damaged retinal ganglion cells. Mol Vis 7: 192–201.
[6]  Lieven CJ, Hoegger MJ, Schlieve CR, Levin LA (2006) Retinal ganglion cell axotomy induces an increase in intracellular superoxide anion. Invest Ophthalmol Vis Sci 47: 1477–1485.
[7]  Liu Q, Ju WK, Crowston JG, Xie F, Perry G, et al. (2007) Oxidative stress is an early event in hydrostatic pressure induced retinal ganglion cell damage. Invest Ophthalmol Vis Sci 48: 4580–4589.
[8]  Thaler S, Fiedorowicz M, Rejdak R, Choragiewicz TJ, Sulejczak D, et al. (2010) Neuroprotective effects of tempol on retinal ganglion cells in a partial optic nerve crush rat model with and without iron load. Exp Eye Res 90: 254–60.
[9]  Levkovitch-Verbin H, Harris-Cerruti C, Groner Y, Wheeler LA, Schwartz M, et al. (2000) RGC death in mice after optic nerve crush injury: oxidative stress and neuroprotection. Invest Ophthalmol Vis Sci 41: 4169–4174.
[10]  Mitchell JB, Samuni A, Krishna MC, DeGraff WG, Ahn MS, et al. (1990) Biologically active metal- independent superoxide dismutase mimics. Biochemistry 29: 2802–2807.
[11]  Thaler S, Fiedorowicz M, Rejdak R, Choragiewicz TJ, Sulejczak D, et al. (2010) Neuroprotective effects of tempol on retinal ganglion cells in a partial optic nerve crush rat model with and without iron load. Exp Eye Res 90: 254–260.
[12]  Tanito M, Li F, Elliott MH, Dittmar M, Anderson RE (2007) Protective effect of TEMPOL derivatives against light-induced retinal damage in rats. Invest Ophthalmol Vis Sci 48: 1900–1905.
[13]  Leung CK, Lindsey JD, Crowston JG, Ju WK, Liu Q, et al. (2008) In vivo imaging of murine retinal ganglion cells. J Neurosci Methods 168: 475–478.
[14]  Leung CK, Lindsey JD, Crowston JG, Lijia C, Chiang S, et al. (2008) Longitudinal profile of retinal ganglion cell damage after optic nerve crush with blue-light confocal scanning laser ophthalmoscopy. Invest Ophthalmol Vis Sci 49: 4898–4902.
[15]  Dibas A, Oku H, Fukuhara M, Kurimoto T, Ikeda T, et al. (2010) Changes in ocular aquaporin expression following optic nerve crush. Mol Vis 16: 330–340.
[16]  Chindasub P, Lindsey JD, Duong-Polk K, Leung CK, Weinreb RN (2013) Inhibition of histone deacetylases 1 and 3 protects injured retinal ganglion cells. Invest Ophthalmol Vis Sci 54: 96–102.
[17]  Raymond ID, Vila A, Huynh UC, Brecha NC (2008) Cyan fluorescent protein expression in ganglion and amacrine cells in a thy1-CFP transgenic mouse retina. Mol Vis 14: 1559–1574.
[18]  Raymond ID, Pool AL, Vila A, Brecha NC (2009) A Thy1-CFP DBA/2J mouse line with cyan fluorescent protein expression in retinal ganglion cells. Vis Neurosci 26: 453–465.
[19]  Wilcox CS (2010) Effects of tempol and redox-cycling nitroxides in models of oxidative stress. Pharmacol Ther 126: 119–145.
[20]  Chatterjee PK, Cuzzocrea S, Brown PA, Zacharowski K, Stewart KN, et al. (2000) Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat. Kidney Int 58: 658–673.
[21]  Hall ED, Vaishnav RA, Mustafa AG (2010) Antioxidant therapies for traumatic brain injury. Neurotherapeutics 7: 51–61.
[22]  Patil G (2008) Hydroxylamine compounds and their methods of use. U.S. Patent No. 2008/0280890A1.
[23]  Kirsch M, Trautmann N, Ernst M, Hofmann HD (2010) Involvement of gp130-associated cytokine signaling in Müller cell activation following optic nerve lesion. Glia 58: 768–779.
[24]  Liu S, Li ZW, Weinreb RN, Xu G, Lindsey JD, et al. (2012) Tracking retinal microgliosis in models of retinal ganglion cell damage. Invest Ophthalmol Vis Sci 53: 6254–6262.
[25]  Schnichels S, Heiduschka P, Julien S (2011) Different spatial and temporal protein expressions of repulsive guidance molecule a and neogenin in the rat optic nerve after optic nerve crush with and without lens injury. J Neurosci Res 89: 490–505.
[26]  Wang X, Archibald ML, Stevens K, Baldridge WH, Chauhan BC (2010) Cyan fluorescent protein (CFP) expressing cells in the retina of Thy1-CFP transgenic mice before and after optic nerve injury. Neurosci Lett 468: 110–114.
[27]  Bodeutsch N, Siebert H, Dermon C, Thanos S (1999) Unilateral injury to the adult rat optic nerve causes multiple cellular responses in the contralateral site. J Neurobiol 38: 116–128.
[28]  Blinderman E, Brown WJ (1966) Maturation and water composition of murine cerebrum, cerebellum, brain stem and spinal cord. Anat Rec 154: 753–757.
[29]  Agrawal HC, Davis JM, Himwich WA (1968) Developmental changes in mouse brain: weight, water content and free amino acids. J Neurochem 15: 917–23.
[30]  Sampugna J, Clements J, Carter TP, Campagnoni AT (1975) Comparison of lipids in total brain tissue from five mouse genotypes. J Neurobiol 16: 259–266.
[31]  Schwab C, Brückner G, Castellano C, Oliverio A, Biesold D (1990) Different levels of acetylcholinesterase and choline acetyltransferase activities in C57Bl/6 and DBA/2 mice are not accompanied with different density of cortical acetylcholinesterase reactive fibers. Neurochem Res 15: 1127–1133.
[32]  Arsham H. Analysis of covariance: comparing two linear regressions. Website of Merrick School of Business, University of Baltimore. Available: Accessed 2013 Apr 4.


comments powered by Disqus